N-methyl-D-aspartate (NMDA) Antagonists - S(+)-ketamine, dextrorphan, and dextromethorphan - Act as calcium antagonists on bovine cerebral arteries

Journal of Neurosurgical Anesthesiology

Volumn 20, Issue 4, 2008, Pages 241-248

  Kamel, Ihab R ^a   Wendling, Woodrow W ^a,b   Chen, Dong ^a   Wendling, Karen S ^c,d   Harakal, Concetta ^b   Carlsson, Christer ^e  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHESTNUT HILL COLLEGE   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e LUND UNIVERSITY   (Sweden)

Author keywords

Cattle; Dextromethorphan; Dextrorphan; L type calcium channel; Nimodipine; S( + ) ketamine; Vascular smooth muscle

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM 45; CALCIUM ANTAGONIST; DEXTROMETHORPHAN; DEXTRORPHAN; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; POTASSIUM; THROMBOXANE A2; TRACER; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DIAGNOSTIC AGENT; N METHYLASPARTIC ACID; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; CALCIUM TRANSPORT; COMPARATIVE STUDY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXPERIMENTAL MODEL; IN VITRO STUDY; MIDDLE CEREBRAL ARTERY; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; CATTLE; CYTOLOGY; DRUG ANTAGONISM; ELECTROSTIMULATION; METABOLISM; MUSCLE TONE; VASCULAR RESISTANCE;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM RADIOISOTOPES; CATTLE; DEXTROMETHORPHAN; DEXTRORPHAN; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; ISOMETRIC CONTRACTION; KETAMINE; MIDDLE CEREBRAL ARTERY; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; N-METHYLASPARTATE; NIMODIPINE; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS;

EID: 58949098904     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31817f523f     Document Type: Article

References (58)

1. Lodge D, Anis NA, Burton NR. Effects of optical isomers of ketamine on excitation of cat and rat spinal neurons by amino acids and acetylcholine. Neurosci Lett. 1982;29:281-286.
2. Church J, Lodge D, Berry SC. Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids. Eur J Pharmacol. 1985;111:185-190.
3. Zeilhofer HU, Swandulla D, Geisslinger G, et al. Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol. 1992;213:155-158.
4. Jansen KL. A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drugs. 2000;32:419-433.
5. Jansen KL, Darracot-Cankovic R. The nonmedical use of ketamine, part two: a review of problem use and dependence. J Psychoactive Drugs. 2001;33:151-158.
6. Schwartz RH. Adolescent use of dextromethorphan. Clin Pediatr. 2005;44:565-568.
7. Steinberg GK, Saleh J, Kunis D. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia. Neurosci Lett. 1988;89:193-197.
8. Du C, Hu R, Hsu CY, et al. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury. J Neurotrauma. 1996;13:215-222.
9. Proescholdt M, Heimann A, Kempski O. Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Res. 2001;904: 245-251.
10. Engelhard K, Werner C, Eberspacher E, et al. The effect of the a2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524-531.
11. Olney JW, Labruyere J, Wang G, et al. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 1991;254:1515-1518.
12. Albers GW, Saenz RE, Moses JA Jr. Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Clin Neuropharmacol. 1992;15:509-514.
13. Albers GW, Atkinson RP, Kelley RE, et al. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Stroke. 1995;26:254-258.
14. Hwang J-Y, Kim Y-H, Ahn Y-H, et al. N-methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp Neurol. 1999;159:124-130.
15. Jevtovic-Todorovic V, Carter LB. The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain. Neurobiol Aging. 2005;26:947-956.
16. Langsjo JW, Maksimow A, Salmi E, et al. S-ketamine anesthesia increases cerebral blood flow in excess of metabolic needs in humans. Anesthesiology. 2005;103:258-268.
17. Lo EH, Sun G-H, Steinberg GK. Effects of NMDA and calcium channel antagonists on regional cerebral blood flow. Neurosci Lett. 1991;131:17-20.
18. Wendling WW, Chen D, Daniels FB, et al. The effects of N-methyl-D-aspartate agonists and antagonists on isolated bovine cerebral arteries. Anesth Analg. 1996;82:264-268.
19. Inan S, Tallarida RJ. Morphine potentiates dextromethorphaninduced vasodilation in rat superior mesenteric artery. Eur J Pharmacol. 2004;486:61-65.
20. Wendling WW, Daniels FB, Chen D, et al. Ketamine directly dilates bovine cerebral arteries by acting as a calcium entry blocker. J Neurosurg Anesthesiol. 1994;6:186-192.
21. Fukuda S, Murakawa T, Takeshita H, et al. Direct effects of ketamine on isolated canine cerebral and mesenteric arteries. Anesth Analg. 1983;62:553-558.
22. Kang BS, Lee YH, Nam TS, et al. Effects of ketamine on contractile responses in vascular smooth muscle. Yonsei Med J. 1990;31: 325-332.
23. Chung HC, Ho ST, Ho W, et al. Partially endothelium-dependent relaxing effect of ketamine on the canine basilar artery in vitro. Anaesthesiol Sinica. 1992;30:1-6.
24. 2+ currents in single smooth muscle cells from rabbit portal vein. Pharmacology. 1992;45:162-169.
25. 2+ movements in A7r5 vascular smooth muscle cells. Anesth Analg. 1996;83:1105-1109.
26. Kaye AD, Banister RE, Anwar M, et al. Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels. Anesth Analg. 1998;87:956-962.
27. Akata T, Izumi K, Nakashima M. Mechanisms of direct inhibitory action of ketamine on vascular smooth muscle in mesenteric resistance arteries. Anesthesiology. 2001;95:452-462.
28. Wendling WW, Harakal C. Effects of calcium antagonists on isolated bovine cerebral arteries: inhibition of constriction and calcium-45 uptake induced by potassium or serotonin. Stroke. 1987; 18:591-598.
29. 2 analogue on bovine cerebral arterial tone and calcium fluxes. Stroke. 1991;22:66-72.
30. Mchedlishvili G. Physiological mechanisms controlling cerebral blood flow. Stroke. 1980;11:240-248.
31. Heistad DD, Kontos HA. Cerebral circulation. In: Shepherd JJ, Abboud FM, eds. Handbook of Physiology, Section 2: The Cardiovascular System, Vol. III, Peripheral Circulation and Organ Blood Flow, Part 1. Bethesda, MD: American Physiologic Society; 1983:137-182.
32. Conner HE, Feniuk W. Role of endothelium in haemoglobininduced contraction of dog basilar artery. Eur J Pharmacol. 1987; 140:105-108.
33. Villamil MF, Rettori V, Barajas L, et al. Extracellular space and the ionic distribution in the isolated arterial wall. Am J Physiol. 1968;214: 1104-1112.
34. Law RO. Techniques and applications of extracellular space determination in mammalian tissues. Experientia. 1982;38:411-421.
35. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculations With Computer Programs. 2nd edn. New York: Springer-Verlag; 1987:117-148.
36. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
37. Schefler WC. Statistics for Health Professionals. Reading, MA: Addison-Wesley; 1984:190-192.
38. Monaghan DT, Bridges RJ, Cotman CW. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol. 1989;29:365-402.
39. Wong EH, Kemp JA. Sites for antagonism on the N-methyl-D- aspartate receptor channel complex. Annu Rev Pharmacol Toxicol. 1991;31:401-425.
40. O'Shaughnessy CT, Lodge D. N-methyl-D-aspartate receptormediated increase in intracellular calcium is reduced by ketamine and phencyclidine. Eur J Pharmacol. 1988;153:201-209.
41. MacDonald JF, Bartlett MC, Mody I, et al. Actions of ketamine, phencyclidine and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurons. J Physiol. 1991;432:483-508.
42. Scriabine A, van den Kerckhoff W. Pharmacology of nimodipine. A review. Ann NY Acad Sci. 1988;522:698-706.
43. Carpenter CL, Marks SS, Watson DL, et al. Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Res. 1988;439: 372-375.
44. 2+ concentration. Neurosci Lett. 1991;124:232-234.
45. Wong BS, Martin CD. Ketamine inhibition of cytoplasmic calcium signaling in rat pheochromocytoma (PC-12) cells. Life Sci. 1993;53: PL359-PL364.
46. 3H]MK-801 binding as functional measures. Brain Res. 1994;22:166-172.
47. Bolger GT, Rafferty MF, Skolnick P. Enhancement of brain calcium antagonist binding by phencyclidine and related compounds. Pharmacol Biochem Behav. 1986;24:417-423.
48. 2+ channels. Neurosci Lett. 1989;105: 227-232.
49. 2+ channels in rat cerebrocortical membranes. Brit J Anaesth. 1996;77:248-253.
50. 2+ channels, and GABAA receptors. Brit J Anaesth. 2003;90:199-211.
51. Lu YF, Sun FY, Zhang LM, Zhang AZ. Phencyclidine receptors in porcine cerebral arteries. Acta Pharmacol Sinica. 1989;10:508-511.
52. Beart PM, Sheehan KA, Manallack DT. Absence of N-methyl-D-aspartate receptors on ovine cerebral microvessels. J Cereb Blood Flow Metab. 1988;8:879-882.
53. Alborch E, Salom JB, Torregrosa G. Calcium channels in cerebral arteries. Pharmacol Ther. 1995;68:1-34.
54. Morel N, Godfraind T. Cerebrovascular effect of calcium antagonists. Eur Neurol. 1990;30(suppl 2):10-15.
55. van Breemen C, Leuten P, Yamamoto H, et al. Calcium activation of vascular smooth muscle. Hypertension. 1986;8(suppl II): II-89-II-95.
56. Loutzenhiser R, van Breemen C. Mechanism of activation of isolated rabbit aorta by PGH2 analogue U-44069. Am J Physiol. 1981; 241:C243-C249.
57. Cauvin C, Loutzenhiser R, van Breemen C. Mechanisms of calcium antagonist-induced vasodilation. Annu Rev Pharmacol Toxicol. 1983; 23:373-396.
58. Coughlan MG, Flynn NM, Kenny D, et al. Differential relaxant effect of high concentrations of intravenous anesthetics on endothelin-constricted proximal and distal canine coronary arteries. Anesth Analg. 1992;74:378-383.